LatestLow-Calorie Diet and Exercise Put Early-Onset Type 2 Diabetes in Remission for 54% of Participants
Cannabis

DEA Judge Halts Cannabis Reclassification: What This Means for Patients

Javier Hasse
DEA Judge Halts Cannabis Reclassification: What This Means for Patients
AnxietyChronic PainEpilepsy
Summary

A DEA administrative law judge has suspended the most significant cannabis reclassification proceeding in the United States after opposing parties requested the inclusion of a new government report in the hearing record. Judge Derek Julius ordered the freeze while evaluating the recommendation that could change cannabis's Schedule I status. This delay affects millions of patients relying on medical marijuana for conditions like chronic pain, anxiety, and epilepsy, as well as researchers studying therapeutic applications. The decision underscores ongoing federal uncertainty regarding cannabis policy despite growing state-level legalization and clinical evidence supporting medical use.

Originally published on

El Planteo

By Javier Hasse

Read full article(opens in new tab)

Fetched: October 2, 2026 at 10:02 AM

Related News

More news you might be interested in

View all
Future Doctors Show Knowledge Gaps in Medical Cannabis Education
Cannabis

Future Doctors Show Knowledge Gaps in Medical Cannabis Education

A survey of 250 medical students beginning their studies at a Michigan university revealed significant knowledge gaps regarding medical cannabis, despite overwhelming majority support for incorporating it into medical curricula. The findings highlight a critical disconnect between student interest in cannabis therapeutics and the lack of formal training on cannabinoid science, clinical applications, and evidence-based dosing. As medical marijuana becomes increasingly legal across the United States and Puerto Rico expands its medical cannabis program, physicians entering practice lack foundational knowledge about cannabis as a treatment option for various conditions. Medical schools must address this educational void to ensure future doctors can competently counsel patients on therapeutic applications, drug interactions, and contraindications. This gap in medical education underscores the urgent need for standardized cannabis medicine curricula in medical training programs.

14 hours ago
Revista Cáñamo
Cannabis
AnxietyCancer

Pennsylvania Brings Medical Cannabis to Hospital Settings for Terminally Ill Patients

Pennsylvania has advanced legislation that would allow terminally ill patients to use medical cannabis within hospital facilities, marking a significant shift in hospital cannabis policies. The new framework establishes specific guidelines for therapeutic use while prohibiting smoking and vaping methods, focusing instead on alternative consumption routes. This legislative development recognizes the potential therapeutic benefits of cannabinoids for end-of-life care and symptom management in hospice and palliative settings. The measure represents growing acceptance of medical cannabis integration within traditional healthcare systems, particularly for patients with limited treatment options.

20 hours ago
Cannabis Magazine
MJBizDaily
Cannabis

Cannabis MSO Verano Prepares for Major Virginia Market Launch

Verano, a major cannabis multistate operator (MSO), is strategically remodeling its Virginia operations ahead of the state's July adult-use cannabis launch. The company is positioning itself to capture market demand through careful timing and infrastructure optimization, avoiding overbuilding while maximizing competitive advantage. This expansion reflects the broader trend of established cannabis operators scaling operations as new markets open across the United States. For patients and consumers in Virginia, this development signals increased access to regulated cannabis products and competitive retail options. Verano's strategic approach demonstrates how MSOs are adapting their business models to capitalize on evolving cannabis legalization.

yesterday
MJBizDaily
Cannabis Farming Standards Reveal Critical Pesticide Testing Gaps in Agriculture
Cannabis

Cannabis Farming Standards Reveal Critical Pesticide Testing Gaps in Agriculture

A farmer's firsthand account of pesticide exposure while cultivating cannabis highlights how the regulated cannabis industry has implemented rigorous testing protocols that far exceed those in conventional agriculture. The cannabis sector's mandatory pesticide residue testing, implemented to ensure consumer safety, serves as a model that could protect agricultural workers and food consumers alike. This investigation explores how cannabis cultivation standards—developed to comply with state regulations—have inadvertently become a template for safer farming practices. The article examines why conventional agriculture lacks similar oversight despite workers and consumers facing comparable health risks from pesticide exposure.

yesterday
High Times